Zacks Research Comments on Patterson Companies, Inc.’s Q2 2025 Earnings (NASDAQ:PDCO)

Patterson Companies, Inc. (NASDAQ:PDCOFree Report) – Research analysts at Zacks Research cut their Q2 2025 EPS estimates for shares of Patterson Companies in a note issued to investors on Tuesday, September 10th. Zacks Research analyst I. Bandyopadhyay now anticipates that the company will post earnings of $0.50 per share for the quarter, down from their prior forecast of $0.53. The consensus estimate for Patterson Companies’ current full-year earnings is $2.33 per share. Zacks Research also issued estimates for Patterson Companies’ Q3 2025 earnings at $0.65 EPS, Q1 2026 earnings at $0.28 EPS, Q2 2026 earnings at $0.48 EPS and Q1 2027 earnings at $0.32 EPS.

Several other equities research analysts have also recently weighed in on the stock. StockNews.com cut shares of Patterson Companies from a “buy” rating to a “hold” rating in a research report on Saturday, June 1st. Morgan Stanley lowered their price objective on shares of Patterson Companies from $30.00 to $28.00 and set an “equal weight” rating for the company in a research report on Thursday, June 20th. UBS Group reduced their target price on Patterson Companies from $27.00 to $24.00 and set a “neutral” rating on the stock in a report on Thursday, September 5th. Bank of America lowered their price target on Patterson Companies from $31.00 to $29.00 and set a “buy” rating for the company in a report on Thursday, August 29th. Finally, Robert W. Baird reduced their price objective on Patterson Companies from $30.00 to $28.00 and set a “neutral” rating on the stock in a research note on Thursday, August 29th. Nine analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $28.40.

Get Our Latest Report on PDCO

Patterson Companies Stock Performance

PDCO opened at $21.09 on Thursday. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.67 and a current ratio of 1.30. Patterson Companies has a 52-week low of $19.96 and a 52-week high of $32.58. The firm has a market cap of $1.85 billion, a P/E ratio of 10.55, a price-to-earnings-growth ratio of 1.50 and a beta of 1.02. The business’s fifty day moving average is $24.04 and its 200-day moving average is $25.04.

Patterson Companies (NASDAQ:PDCOGet Free Report) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.08). Patterson Companies had a net margin of 2.58% and a return on equity of 19.87%. The company had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter last year, the firm posted $0.40 earnings per share. The company’s quarterly revenue was down 2.3% on a year-over-year basis.

Insider Activity at Patterson Companies

In other news, CEO Donald Zurbay sold 5,875 shares of Patterson Companies stock in a transaction on Wednesday, July 3rd. The shares were sold at an average price of $23.71, for a total transaction of $139,296.25. Following the transaction, the chief executive officer now owns 237,288 shares in the company, valued at $5,626,098.48. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, CEO Donald Zurbay sold 5,875 shares of Patterson Companies stock in a transaction that occurred on Wednesday, July 3rd. The stock was sold at an average price of $23.71, for a total value of $139,296.25. Following the transaction, the chief executive officer now directly owns 237,288 shares of the company’s stock, valued at $5,626,098.48. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Kevin Michael Barry sold 1,216 shares of the stock in a transaction that occurred on Wednesday, July 3rd. The shares were sold at an average price of $23.72, for a total transaction of $28,843.52. Following the sale, the chief financial officer now directly owns 41,605 shares of the company’s stock, valued at approximately $986,870.60. The disclosure for this sale can be found here. Insiders sold a total of 17,149 shares of company stock worth $415,851 in the last quarter. 1.50% of the stock is owned by insiders.

Institutional Trading of Patterson Companies

A number of institutional investors have recently bought and sold shares of PDCO. Sanctuary Advisors LLC acquired a new position in Patterson Companies in the second quarter valued at approximately $429,000. Aristides Capital LLC bought a new stake in shares of Patterson Companies in the 2nd quarter valued at $246,000. Point72 Asset Management L.P. increased its stake in shares of Patterson Companies by 1,574.9% in the 2nd quarter. Point72 Asset Management L.P. now owns 340,000 shares of the company’s stock valued at $8,201,000 after acquiring an additional 319,700 shares in the last quarter. Algert Global LLC acquired a new position in shares of Patterson Companies during the 2nd quarter valued at $1,939,000. Finally, Scientech Research LLC boosted its stake in Patterson Companies by 30.2% during the second quarter. Scientech Research LLC now owns 11,697 shares of the company’s stock worth $282,000 after acquiring an additional 2,714 shares in the last quarter. Institutional investors own 85.43% of the company’s stock.

Patterson Companies Company Profile

(Get Free Report)

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.

Featured Stories

Earnings History and Estimates for Patterson Companies (NASDAQ:PDCO)

Receive News & Ratings for Patterson Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Patterson Companies and related companies with MarketBeat.com's FREE daily email newsletter.